Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
13017.0000 -264.00 (-1.99%)
NSE Aug 01, 2025 15:31 PM
Volume: 308.9K
 

13017.00
-1.99%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Neuland Laboratories Ltd. is trading above its 150 day SMA of 12575.5
More from Neuland Laboratories Ltd.
Recommended